Cizzle Biotechnology (LON:CIZ) Posts Earnings Results

Cizzle Biotechnology (LON:CIZ) released its quarterly earnings results on Tuesday. The company reported GBX (0.17) earnings per share for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Price Performance

CIZ opened at GBX 2.80 on Tuesday. The company has a fifty day simple moving average of GBX 2 and a 200 day simple moving average of GBX 1.71. The firm has a market cap of £11.10 million, a price-to-earnings ratio of -16.47 and a beta of 0.51. Cizzle Biotechnology has a twelve month low of GBX 1.20 and a twelve month high of GBX 3.30. The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.